New technology also can be used to turn off peanut and other food allergies
In an entirely new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell, to convince the immune system not to attack it, according to new Northwestern Medicine research. As a result, the allergic reaction in the airways is shut down long- term and an asthma attack prevented.
The technology can be applied to food allergies as well. The nanoparticle is currently being tested in a mouse model of peanut allergy, similar to food allergy in humans.
“The findings represent a novel, safe and effective long-term way to treat and potentially ‘cure’ patients with life-threatening respiratory and food allergies,” said senior author Stephen Miller, the Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine. “This may eliminate the need for life-long use of medications to treat lung allergy.”
It’s the first time this method for creating tolerance in the immune system has been used in allergic diseases. The approach has been used in autoimmune diseases including multiple sclerosis and celiac disease in previous preclinical Northwestern research.
The asthma allergy study was in mice, but the technology is progressing to clinical trials in autoimmune disease. The nanoparticle technology is being developed commercially by Cour Pharmaceuticals Development Co., which is working with Miller to bring this new approach to patients. A clinical trial using the nanoparticles to treat celiac disease is in development.
The new study on nanoparticles treating asthma was published April 18 in the Proceedings of the National Academy of Sciences.
“It’s a universal treatment,” Miller said. “Depending on what allergy you want to eliminate, you can load up the nanoparticle with ragweed pollen or a peanut protein.”
The nanoparticles are composed of an FDA-approved biopolymer called PLGA that includes lactic acid and glycolic acid.
Also a senior author is Lonnie Shea, adjunct professor of chemical and biological engineering at Northwestern’s McCormick School of Engineering and of obstetrics and gynecology at Feinberg, and chair of biomedical engineering at the University of Michigan.
When the allergen-loaded nanoparticle is injected into the bloodstream of mice, the immune system isn’t concerned with it because it sees the particle as innocuous debris. Then the nanoparticle and its hidden cargo are consumed by a macrophage, essentially a vacuum-cleaner cell.
“The vacuum-cleaner cell presents the allergen or antigen to the immune system in a way that says, ‘No worries, this belongs here,’” Miller said. The immune system then shuts down its attack on the allergen, and the immune system is reset to normal.
The allergen, in this case egg protein, was administered into the lungs of mice who have been pretreated to be allergic to the protein and already had antibodies in their blood against it. So when they were re-exposed to it, they responded with an allergic response like asthma. After being treated with the nanoparticle, they no longer had an allergic response to the allergen.
The approach also has a second benefit. It creates a more normal, balanced immune system by increasing the number of regulatory T cells, immune cells important for recognizing the airway allergens as normal. This method turns off the dangerous Th2 T cell that causes the allergy and expands the good, calming regulatory T cells.
The Latest on: Nanoparticles asthma allergies
via Google News
The Latest on: Nanoparticles asthma allergies
- Asthma and COPD Drugs Market Share Value, Size Analysis, Future Trends, Growth Insights and Industry Dynamics By 2025on March 19, 2020 at 4:59 am
This can be attributed to the rising patient population suffering from asthma and COPD in the region. According to the American Academy of Allergy Asthma & Immunology, in 2016, approximately 8.3% ...
- Allergy Treatment Market Size to Accelerate at a Rapid CAGR of 5.5% from 2017 to 2025on March 17, 2020 at 7:07 am
The global allergy treatment market is likely to be driven by the growing need to meet the huge unmet demand in developing parts of the world and rising prevalence of asthma. Some of the well ...
- Ultrafine particles: unique physicochemical properties relevant to health and diseaseon March 17, 2020 at 1:20 am
Li, N. et al. A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): why ambient ultrafine and engineered nanoparticles should receive special attention for ...
- Asthma patients found to have higher levels of iron in their lungson March 16, 2020 at 5:00 pm
New research from the University of Newcastle and Hunter Medical Research Institute, Australia, has suggested that people with asthma have a greater build-up of iron in their lung tissue than ...
- Allergy Diagnostics Market Outlook, Current Strategies and Growth by Top Companies: Thermo Fisher Scientific, Omega Diagnostics Groupon March 13, 2020 at 9:11 am
According to American Academy of Allergy, Asthma & Immunology ... Moreover, the exposure to the small nanoparticles in the air tends to exacerbate allergic inflammations. These factors are ...
- A Scientific Look at Botanical Plants and Supplements Against Coronaviruson March 11, 2020 at 5:00 pm
Licorice Root (Glycyrrhizin Acid) In traditional medicine licorice root has been used to relieve and treat ulcers, sore throats, bronchitis, coughs, adrenal insufficiencies and allergic diseases ...
- European Workers Face Increasing Health Risks From Hazardous Substanceson March 5, 2020 at 4:00 pm
The report, Expert Forecast on Emerging Chemical Risks, identifies the main groups of substances that could pose new and increasing risks to workers, contributing to diseases ranging from allergies, ...
- Allergies Newson June 15, 2019 at 12:45 am
Prescribing antibiotics to children may raise the risk of children going on to develop allergies in later life, a new study suggests. A biodegradable nanoparticle has been used to treat asthma and ...
- Concern mounting over common food additive linked to cancer, bowel diseaseon May 13, 2019 at 7:29 pm
asthma, allergies and reproductive issues." "We've been exposed to nanoparticles all our lives. Mr Chrzanowski said. "However, we are sort of entering the stage where we are over-exposed.
- Andrea R. Ferroon January 31, 2018 at 2:21 am
“Distribution of nanoparticles near a major U.S. and Canada trade bridge ... “Time for new methods for avoidance of HDM and other allergens.” Current Allergy and Asthma Reports, Vol. 12, pp. 465-477.
via Bing News